NF1 c.283dup ;(p.A95Gfs*12)

Variant ID: 17-29486105-T-TG

NM_001042492.2(NF1):c.283dup;(p.A95Gfs*12)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine.

Oncotarget
Cabezón, Marta M; Bargay, Joan J; Xicoy, Blanca B; García, Olga O; Borrás, Josep J; Tormo, Mar M; Marcé, Sílvia S; Pedro, Carme C; Valcárcel, David D; Jiménez, Maria-José MJ; Guàrdia, Ramón R; Palomo, Laura L; Brunet, Salut S; Vall-Llovera, Ferran F; Garcia, Antoni A; Feliu, Evarist E; Zamora, Lurdes L; ,
Publication Date: 2018-04-10

Variant appearance in text: NF1: 282_283insG
PubMed Link: 29721207
Variant Present in the following documents:
  • Main text
  • oncotarget-09-19342.pdf
View BVdb publication page